ASX - By Stock
|
ASN |
Re:
Ann: Successful Completion of Green River Sample Demo Plant
|
|
Earth Angel
|
61 |
21K |
16 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
61
|
21K
|
16
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Flow Test - Second Light Oil Discovery
|
|
Earth Angel
|
148 |
52K |
16 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
148
|
52K
|
16
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: AT1 secures significant order for HIV self-tests
|
|
Earth Angel
|
9 |
2.8K |
5 |
15/04/24 |
15/04/24 |
ASX - By Stock
|
9
|
2.8K
|
5
|
|
ASX - By Stock
|
OAR |
Re:
Ann: OAR Raises $1M to Advance Uranium Exploration
|
|
Earth Angel
|
9 |
1.5K |
0 |
05/04/24 |
05/04/24 |
ASX - By Stock
|
9
|
1.5K
|
0
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Continues Deep Drilling at Green River Lithium Project
|
|
Earth Angel
|
36 |
10K |
6 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
36
|
10K
|
6
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Anson Continues Deep Drilling at Green River Lithium Project
|
|
Earth Angel
|
36 |
10K |
0 |
28/02/24 |
28/02/24 |
ASX - By Stock
|
36
|
10K
|
0
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Positive Phase 1 MEND Study Top-Line Results
|
|
Earth Angel
|
152 |
45K |
23 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
152
|
45K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Extension Study Begins, Analysis Suggests Survival Benefit
|
|
Earth Angel
|
197 |
51K |
29 |
15/02/24 |
15/02/24 |
ASX - By Stock
|
197
|
51K
|
29
|
|
ASX - By Stock
|
PAA |
Re:
Ann: FightMND Invites PharmAust to Apply for Phase 2/3 Funding
|
|
Earth Angel
|
56 |
15K |
18 |
22/12/23 |
22/12/23 |
ASX - By Stock
|
56
|
15K
|
18
|
|
ASX - By Stock
|
NWC |
Re:
Ann: $11 Million Royalty Funding Completed
|
|
Earth Angel
|
9 |
3.5K |
4 |
22/11/23 |
22/11/23 |
ASX - By Stock
|
9
|
3.5K
|
4
|
|
ASX - By Stock
|
RGT |
Re:
Ann: MGC Secures US$7.9 Million in Firm Commitments
|
|
Earth Angel
|
20 |
7.3K |
2 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
20
|
7.3K
|
2
|
|
ASX - By Stock
|
AGH |
Re:
Peak/althea media thread
|
|
Earth Angel
|
20 |
11K |
13 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
20
|
11K
|
13
|
|
ASX - By Stock
|
WBT |
Re:
Ann: Weebit Nano receives first revenue
|
|
Earth Angel
|
166 |
67K |
10 |
06/11/23 |
06/11/23 |
ASX - By Stock
|
166
|
67K
|
10
|
|
ASX - By Stock
|
TON |
Re:
CHINA RESTRICTS GRAPHITE EXPORTS AS OF DEC 1
|
|
Earth Angel
|
31 |
11K |
4 |
23/10/23 |
23/10/23 |
ASX - By Stock
|
31
|
11K
|
4
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Major Mineral Resource Upgrade at Paradox Lithium Project
|
|
Earth Angel
|
79 |
23K |
24 |
16/10/23 |
16/10/23 |
ASX - By Stock
|
79
|
23K
|
24
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Final MND Patient in Cohort 4 Successfully Completes Dosing
|
|
Earth Angel
|
125 |
24K |
21 |
14/10/23 |
14/10/23 |
ASX - By Stock
|
125
|
24K
|
21
|
|
ASX - By Stock
|
RGT |
Re:
Ann: Annual Report to shareholders
|
|
Earth Angel
|
23 |
8.4K |
3 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
23
|
8.4K
|
3
|
|
ASX - By Stock
|
TON |
Re:
Ton valuations
|
|
Earth Angel
|
10 |
3.6K |
2 |
11/10/23 |
11/10/23 |
ASX - By Stock
|
10
|
3.6K
|
2
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
Earth Angel
|
90 |
34K |
1 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
90
|
34K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
Earth Angel
|
90 |
34K |
0 |
29/09/23 |
29/09/23 |
ASX - By Stock
|
90
|
34K
|
0
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
Earth Angel
|
90 |
34K |
3 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
90
|
34K
|
3
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Phase 3 Common Cold Trial Results
|
|
Earth Angel
|
90 |
34K |
3 |
16/09/23 |
16/09/23 |
ASX - By Stock
|
90
|
34K
|
3
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Africa Down Under Presentation
|
|
Earth Angel
|
121 |
36K |
16 |
07/09/23 |
07/09/23 |
ASX - By Stock
|
121
|
36K
|
16
|
|
ASX - By Stock
|
TON |
Re:
Ann: Reinstatement to Quotation
|
|
Earth Angel
|
6 |
3.9K |
5 |
30/08/23 |
30/08/23 |
ASX - By Stock
|
6
|
3.9K
|
5
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
Earth Angel
|
25 |
8.2K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
25
|
8.2K
|
1
|
|
ASX - By Stock
|
FRE |
Re:
Ann: Firebrick Phase 3 Trial Closes with 500 Subjects
|
|
Earth Angel
|
25 |
8.2K |
4 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
25
|
8.2K
|
4
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
Earth Angel
|
19K |
5.6M |
2 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
19K
|
5.6M
|
2
|
|
ASX - By Stock
|
ASN |
Re:
ASN General Discussion
|
|
Earth Angel
|
19K |
5.6M |
0 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
19K
|
5.6M
|
0
|
|
ASX - By Stock
|
FRE |
Re:
News: FRE Firebrick Pharma Says Firebrick COVID-19 Trial Achieves Primary Endpoint
|
|
Earth Angel
|
1 |
670 |
3 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
1
|
670
|
3
|
|
ASX - By Stock
|
IPD |
Re:
Ann: APPENDIX 4C - Quarterly Activities Report
|
|
Earth Angel
|
54 |
17K |
6 |
24/07/23 |
24/07/23 |
ASX - By Stock
|
54
|
17K
|
6
|
|
ASX - By Stock
|
BCN |
Re:
Ann: Lady Ida Project Update
|
|
Earth Angel
|
81 |
24K |
5 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
81
|
24K
|
5
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Trading Halt
|
|
Earth Angel
|
62 |
21K |
23 |
15/07/23 |
15/07/23 |
ASX - By Stock
|
62
|
21K
|
23
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Earth Angel
|
126 |
28K |
12 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
126
|
28K
|
12
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Canine Trial Update
|
|
Earth Angel
|
126 |
28K |
14 |
13/07/23 |
13/07/23 |
ASX - By Stock
|
126
|
28K
|
14
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Trading Halt
|
|
Earth Angel
|
46 |
13K |
1 |
12/07/23 |
12/07/23 |
ASX - By Stock
|
46
|
13K
|
1
|
|
ASX - By Stock
|
ASN |
Re:
S.P prediction for 31 December.
|
|
Earth Angel
|
318 |
107K |
1 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
318
|
107K
|
1
|
|
ASX - By Stock
|
TON |
Re:
Ann: Definitive Feasibility Study Update Completed
|
|
Earth Angel
|
24 |
10K |
4 |
11/07/23 |
11/07/23 |
ASX - By Stock
|
24
|
10K
|
4
|
|
ASX - By Stock
|
PAA |
Re:
Ann: MND Biomarkers and Pharmacodynamics Results
|
|
Earth Angel
|
396 |
82K |
27 |
04/07/23 |
04/07/23 |
ASX - By Stock
|
396
|
82K
|
27
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Trading Halt
|
|
Earth Angel
|
51 |
12K |
29 |
01/07/23 |
01/07/23 |
ASX - By Stock
|
51
|
12K
|
29
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Flow Testing Program and Post Well Analysis Update
|
|
Earth Angel
|
79 |
34K |
1 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
79
|
34K
|
1
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Flow Testing Program and Post Well Analysis Update
|
|
Earth Angel
|
79 |
34K |
2 |
27/06/23 |
27/06/23 |
ASX - By Stock
|
79
|
34K
|
2
|
|
ASX - By Stock
|
88E |
Re:
Ann: Hickory-1 Flow Testing Program and Post Well Analysis Update
|
|
Earth Angel
|
79 |
34K |
15 |
23/06/23 |
23/06/23 |
ASX - By Stock
|
79
|
34K
|
15
|
|
ASX - By Stock
|
MNB |
Re:
Ann: Minbos Signs EPCM Contract for Cabinda Phosphate Project
|
|
Earth Angel
|
119 |
34K |
10 |
16/06/23 |
16/06/23 |
ASX - By Stock
|
119
|
34K
|
10
|
|
ASX - By Stock
|
AT1 |
Re:
Ann: Exclusive Agreement for HIV Testing Signed with Newfoundland
|
|
Earth Angel
|
2 |
1.4K |
5 |
14/06/23 |
14/06/23 |
ASX - By Stock
|
2
|
1.4K
|
5
|
|
ASX - By Stock
|
ASN |
Re:
Ann: Paradox Lithium Plant Front End Engineering & Design Study
|
|
Earth Angel
|
167 |
46K |
3 |
25/05/23 |
25/05/23 |
ASX - By Stock
|
167
|
46K
|
3
|
|
ASX - By Stock
|
RGT |
Re:
Ann: ArtemiC Listed as OTC Drug in USA, AMC Places US$2m Order
|
|
Earth Angel
|
58 |
22K |
1 |
16/05/23 |
16/05/23 |
ASX - By Stock
|
58
|
22K
|
1
|
|
ASX - By Stock
|
PAA |
Re:
Ann: Independent tests show MPL retains long-term shelf-life
|
|
Earth Angel
|
4 |
1.4K |
12 |
10/05/23 |
10/05/23 |
ASX - By Stock
|
4
|
1.4K
|
12
|
|
ASX - By Stock
|
PAA Biotech |
Re:
MONEPANTEL - A Pan-Cancer Wonder Drug
|
|
Earth Angel
|
84 |
22K |
8 |
08/05/23 |
08/05/23 |
ASX - By Stock
|
84
|
22K
|
8
|
|
ASX - By Stock
|
TON |
Re:
Ann: A$5m Placement to Shandong Yulong Completed
|
|
Earth Angel
|
10 |
6.3K |
1 |
01/05/23 |
01/05/23 |
ASX - By Stock
|
10
|
6.3K
|
1
|
|
ASX - By Stock
|
KNM |
Re:
Ann: CONFIRMATION 1st A$700k PAYMT FOR 40k UNIT CONNECT ALL KIDS
|
|
Earth Angel
|
2 |
976 |
0 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
2
|
976
|
0
|
|